You are here

  • Home
  • Archive
  • Volume 70, Issue 11
  • The influence of proton pump inhibitor therapy on the outcome of infliximab therapy in inflammatory bowel disease: a patient-level meta-analysis of randomised controlled studies

Article metrics

Article menu
Download PDFPDF
Inflammatory bowel disease
Original research
The influence of proton pump inhibitor therapy on the outcome of infliximab therapy in inflammatory bowel disease: a patient-level meta-analysis of randomised controlled studies

 

Online download statistics by month:

Online download statistics by month: December 2020 to March 2024

AbstractFullPdf
Dec 2020375216395
Jan 20213167252172
Feb 20211596107108
Mar 20218437870
Apr 20213534644
May 20211751721
Jun 202119167
Jul 2021201812
Aug 202117168
Sep 202118179
Oct 20212340222103
Nov 2021114812894
Dec 20215807142
Jan 20226047833
Feb 20223803820
Mar 20223393012
Apr 20223373714
May 2022314245
Jun 20223482413
Jul 20222682712
Aug 20223303014
Sep 20223173413
Oct 2022219235
Nov 2022139183
Dec 2022130127
Jan 202310883
Feb 2023183134
Mar 2023102104
Apr 2023148134
May 202311152
Jun 2023124103
Jul 20235481
Aug 2023109144
Sep 2023130133
Oct 202317061
Nov 2023348113
Dec 20239121
Jan 20249587
Feb 20249974
Mar 20249752
Total197221659982